Emergency Contraceptive Pills Market to grow with a CAGR of 4.43%
Increasing
healthcare infrastructure and a supportive regulatory environment are the major
drivers for the Global Emergency Contraceptive Pills Market.
According
to TechSci Research report, “Global Emergency Contraceptive Pills Market Industry
Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Emergency Contraceptive
Pills Market has valued at USD 545.60 million in 2022 and is anticipated to
witness an impressive growth in the forecast period with a CAGR of 4.43%
through 2028. This can be due to
collaborations and partnerships among leading companies with a diverse approach
to merge the expertise of individual companies and to strengthen their position
in the market.
Innovations
in product development can drive the demand for Emergency Contraceptive Pills
(ECPs) in the Global Emergency Contraceptive Pills Market. Ongoing research and
development efforts can lead to the creation of more effective and
well-tolerated ECP formulations. Innovations in formulation can result in pills
that are easier to take, have reduced side effects, and offer higher efficacy. Innovations
may extend the window of effectiveness for ECPs, allowing individuals more time
to use them after unprotected sex. This extended timeframe can make ECPs even
more reliable and accessible. Efforts to reduce side effects associated with
ECPs, such as nausea or breast tenderness, can lead to greater user
satisfaction and adherence, driving demand for these products. Innovations in
product development may result in alternative delivery methods for emergency
contraception, such as transdermal patches, vaginal rings, or intramuscular
injections. These methods can offer convenience and potentially improve
efficacy. Innovations in regulatory approval may lead to more ECP products
being available over the counter without a prescription. This can increase
access and demand among consumers. ECP manufacturers may innovate by offering
comprehensive contraceptive solutions that include not only ECPs but also
regular contraception methods. This approach can promote consistent
contraceptive use. Innovations in packaging can make ECPs more user-friendly
and convenient, which may encourage individuals to keep them on hand for
emergencies.
Emergency
contraceptive pills (ECPs) refer to birth control medications used for
preventing unwanted pregnancies. They are manufactured using synthetic
hormones, such as levonorgestrel, which delays ovulation, changes the linings
of the uterus, and prevents egg fertilization. ECPs are widely used during the
failure of traditional methods of contraception, after unprotected sexual
intercourse, as a backup for missing routine birth control pills, and by the
victims of sexual assault crimes. They are safe, cost-effective, accessible,
and highly convenient medications that do not cause long-term fertility issues,
successfully prevent unintended pregnancies, and eliminate the need for
abortions.
In
November 2022, Major global pharmaceutical company Lupin Limited (Lupin)
announced that its Abbreviated New Drug Application (ANDA), Drospirenone
Tablets, 4 mg, to market a generic version of Slynd Tablets, 4 mg, of Exeltis
USA Inc., has received provisional approval from the United States Food and
Drug Administration (FDA). An international pharmaceutical firm with a focus on
innovation, Lupin is based in Mumbai, India. The company creates and promotes a
wide variety of branded and generic formulations, biotechnology goods, and APIs
in more than 100 markets in the Americas, Europe, the Middle East, India, and
South Africa.
Browse over XX market data Figures and spread through 110 Pages and an
in-depth TOC on "Emergency Contraceptive Pills Market.”
Cultural
and religious beliefs can present challenges in the Global Emergency
Contraceptive Pills (ECPs) Market. These challenges can influence individuals'
attitudes toward emergency contraception and affect the availability and
acceptance of these pills in various regions. Some religious and cultural
belief’s view contraception, including emergency contraception, as morally or
ethically unacceptable. This can lead to resistance against the use of ECPs
among individuals who adhere to such beliefs. Cultural and societal norms in
certain regions may stigmatize discussions about contraception, especially
outside of marital relationships. This stigma can deter individuals from
seeking or using ECPs due to concerns about judgment or social pressure. Cultural
and religious influences can contribute to limited awareness or misinformation
about emergency contraception. Individuals may not be fully informed about the
availability and proper use of ECPs. In some countries or regions with strong
religious influences, there may be legal or regulatory restrictions on the sale
and distribution of ECPs. These restrictions can limit access to emergency
contraception. The beliefs and attitudes of healthcare providers, who may be
influenced by cultural or religious values, can impact the quality of
information and services related to ECPs. Providers who have moral objections
may be less likely to offer ECPs or provide comprehensive information.
Global Emergency Contraceptive Pills Market segmentation
is based on
Type, Distribution Channel, and Region.
Based on Type, Global Emergency Contraceptive Pills Market is segmented into Combination
Pills, Progesterone Pills, and Others. Progestin-only pills, often referred to as "progesterone
pills" or mini-pills, are a type of oral contraceptive pill that contains
a synthetic progestin hormone (not natural progesterone) but no estrogen. These
pills are used for contraception and are sometimes prescribed to women who may
not tolerate or should not take birth control pills containing estrogen.
Progestin-only pills contain a
synthetic progestin hormone as their active ingredient. They do not contain
estrogen, which distinguishes them from combination birth control pills that
contain both estrogen and progestin. Progestin-only pills primarily work by
thickening cervical mucus, making it more difficult for sperm to reach and
fertilize an egg. They also make the uterine lining less receptive to
implantation, further reducing the chances of pregnancy. In some cases, they
may suppress ovulation, but this is less consistent compared to combination
birth control pills. Progestin-only pills are effective at preventing pregnancy
when taken correctly and consistently. However, they require precise timing,
with a strict daily regimen. Missing a pill or taking it at significantly
different times can decrease their effectiveness.
Based on Region, North America dominated the Global Emergency
Contraceptive Pills Market. There is a strong tradition of women's
rights and reproductive health advocacy in North America. This has led to
efforts to improve access to contraception, including emergency contraception. North
America is home to many major pharmaceutical companies that manufacture and
distribute emergency contraceptive pills. The presence of these companies in
the region contributes to market dominance. Cultural attitudes in North
America, while diverse, generally tend to be more accepting of contraception
and family planning, which can lead to higher usage rates. The region also
invests significantly in research and development of pharmaceutical products,
leading to the development of newer and more effective emergency contraceptive
options.
Asia-pacific region to fastest growth in
the Global Emergency Contraceptive Pills Market. The Asia-Pacific region is
home to a significant portion of the world's population, with several densely
populated countries. The sheer size of the population can contribute to a
higher demand for emergency contraceptive pills. Rapid urbanization and
changing demographics in many Asian countries have led to shifts in lifestyle
and sexual behavior, which can increase the likelihood of unprotected sex and
the need for emergency contraception. Public health campaigns and efforts to
raise awareness about sexual and reproductive health have been expanding in the
Asia-Pacific region. Increased awareness can lead to greater knowledge about
emergency contraception and its availability. Improved access to healthcare
services, including family planning and contraception, in some parts of the
region can make emergency contraceptive pills more accessible to a larger
population. Attitudes toward contraception and family planning can vary widely
across the region. In some countries, cultural and social norms may become more
accepting of emergency contraception, leading to increased usage.
Some
of the major companies operating in the Global
Emergency Contraceptive Pills Market include:
- Afaxys
Pharma LLC
- Bayer
AG
- Combe
Inc.
- Foundation
Consumer Healthcare LLC
- Gedeon
Richter Plc
- HLL
Lifecare Ltd.
- Knoll
Healthcare Pvt. Ltd.
- Laboratoire
HRA Pharma SAS
- Lupin
Ltd.
- Mankind
Pharma Ltd.
Download Free Sample Report
Customers can also request
10% free customization on this report.
“Certain areas, particularly in
North America, are projected to exert significant demand for contraceptive
pills. The growth in the competitive landscape and the presence of
well-established companies in the market, committed to enhance the overall
wellbeing of people each year, are expected to contribute to a remarkable
growth of the Global Emergency Contraceptive Pills Market in the forecast
period," said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based Global management consulting firm.
Emergency Contraceptive Pills Market – Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type (Combination
Pills, Progesterone Pills, and Others),
by Distribution Channel (Retail Stores, Online Stores, and Others), by region, and
Competition evaluated
the future growth potential of Global Emergency Contraceptive Pills Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide innovative market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Emergency Contraceptive Pills Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com